FDA NDC Directory · JSON-LD · Markdown
NDC 68727-745 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
| Generic name | (daunorubicin and cytarabine) liposome |
|---|---|
| Labeler / Manufacturer | Jazz Pharmaceuticals, Inc. |
| Marketing category | New Drug Application (innovator) · App NDA209401 |
| Dosage form / route | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · INTRAVENOUS |
| Active ingredients | CYTARABINE (100 mg/20mL) DAUNORUBICIN (44 mg/20mL) |
| Marketing started | 20170803 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).